europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Interview with… Agne Vaitkeviciene, Executive Director of LBTA

28/04/2021
INTERVIEW
Agne LBTA

About Agne Vaitkeviciene

Agne Vaitkeviciene holds a BS in molecular biology (Vilnius University, Lithuania) and MS in organ, tissue and cell donation (University of Barcelona, Spain). Since 2006 she has been working in the field of cell therapy. In 2013 Agne Vaitkeviciene co-founded a life science start-up company and managed its activities in the field of advanced therapy medicinal product research and manufacturing as CEO until 2019.

Since 2019 she is actively involved as an expert in EU programs, such as IMI2, EIT Health Innostars and consults biotechnology companies in life science product development management. For the last 3 years Agne Vaitkeviciene has been actively involved in life science expert groups within governmental organizations such as “Enterprise Lithuania”, Science, Innovation and Technology Agency, “Invest Lithuania” and others. Lithuanian biotechnology association elected Agne as a vice-president in 2019 and delegated responsibilities of coordinating foreign affairs and startup support activities within the association. In 2020 Agne Vaitkeviciene became an executive director of Lithuanian biotechnology association. Agne is a board member at Vilnius University Life Science Center and Center of Innovative Medicine. From 2021 February Agne joined US based company Cureline Group Inc., as a Chief Operating Officer to run the branch "Cureline Baltic" in Vilnius, Lithuania.

Interview with... Agne Vaitkeviciene, Vice-President of the Lithuanian Biotechnology Association (LBTA)

1) What inspired the foundation of LBTA?
Since the foundation of the Lithuanian Biotechnology Association in 2003, the association had one main objective: to unite and bring together experts from the country's biotechnology sector. To this day, we aim to foster this idea, while actively striving to involve as many profound biotechnology professionals from business and academia, as well as actively communicating about the ever-changing and growing sector with the society.

2) What are the priorities of your members in Lithuania?
Lithuanian biotechnology association focus on three priority areas covering life sciences, health technologies and bioeconomy. Our members consist of academia, SMEs and corporations operating in the field of biotechnology. We believe that fostering stronger academia-business collaboration and supporting start-up ecosystem acceleration processes, as well as enabling regulatory flexibility for technological implementation are the key priority tasks for our members.

3) How does Lithuania want to position itself within the European biotech economy?
Lithuania’s life science sector is one of the fastest growing in Europe. The contribution of the biotechnology industry to Lithuania’s GDP grew from 0.82% in 2010 and to 2.38% in 2019. In 2020, during the pandemic, sector’s revenue has increased by about 1.5 times and preliminary data shows, that it will be reaching 3.5% of Lithuania’s GDP. Our sector has repeatedly demonstrated the impact on the global biotech arena, starting from Lithuanian-based companies like Thermo fisher Scientific, to the development of niche technologies in universities or start-ups. Globally leading technologies are focused in the field of gene engineering, biomolecule synthesis, synthetic biology and omic technologies. Following the direction of EU Green Deal, Lithuania’s biotechnology sector emphasises its contribution within biotechnology-based bioeconomy seeking to build strong collaborative initiatives.

4) What partnerships are you looking to achieve in EuropaBio?
We are seeking to support academia and biotech industry in Lithuania to become a significant part of Europe biotechnology progress and growth. Therefore, we are open for collaborative projects, acceleration indicatives, international partnerships. We believe that Lithuania, as well as other Baltic states, are unintentionally overlooked and could become strong force for Europe’s goals of the future.

Download the full INTERVIEW below.

Group 1302

Interview with Lithuanian Biotechnology Association


Download
2021_04_G_O_Interview-with…-LBTADownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/03/2023

Unlocking the Potential of Biotechnology Innovation for Patients


Read more
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more
01/03/2023

Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies